Published in Brain Res on August 03, 1981
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats. Front Pharmacol (2016) 0.75
Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A (1988) 11.96
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature (1996) 4.52
Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science (1999) 4.31
Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science (1997) 3.77
Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci U S A (1995) 2.66
Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol. J Pharmacol Exp Ther (1986) 2.30
Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J Pharmacol Exp Ther (1988) 2.29
Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci (1997) 2.23
Microdialysis measurement of cortical and hippocampal acetylcholine release during sleep-wake cycle in freely moving cats. Brain Res (1995) 1.90
Differential responsiveness of dopamine transmission to food-stimuli in nucleus accumbens shell/core compartments. Neuroscience (1999) 1.86
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol (1986) 1.73
Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci (1994) 1.63
Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. J Neurosci (1997) 1.61
Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem (1990) 1.51
Amphetamine, cocaine, phencyclidine and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience (1989) 1.49
Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res (2001) 1.46
Disodium cromoglycate versus diet in the treatment and prevention of nickel-positive pompholyx. Contact Dermatitis (1990) 1.42
Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J Neurosci (2001) 1.40
Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state. Eur J Neurosci (1999) 1.38
Dopamine release and metabolism in awake rats after systemic neuroleptics as studied by trans-striatal dialysis. J Neurosci (1985) 1.31
A dopamine-mu1 opioid link in the rat ventral tegmentum shared by palatable food (Fonzies) and non-psychostimulant drugs of abuse. Eur J Neurosci (1998) 1.26
Stimulation of in vivo dopamine transmission in the bed nucleus of stria terminalis by reinforcing drugs. J Neurosci (2000) 1.23
Enhancement of memory in cannabinoid CB1 receptor knock-out mice. Eur J Pharmacol (1999) 1.19
Contribution of blockade of the noradrenaline carrier to the increase of extracellular dopamine in the rat prefrontal cortex by amphetamine and cocaine. Eur J Neurosci (1997) 1.15
Differential inhibitory effects of a 5-HT3 antagonist on drug-induced stimulation of dopamine release. Eur J Pharmacol (1989) 1.14
Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Life Sci (1998) 1.14
Effects of massage on alpha motoneuron excitability. Phys Ther (1991) 1.14
Caffeine and the dopaminergic system. Behav Pharmacol (2005) 1.13
Self-inhibitory dopamine receptors: their role in the biochemical and behavioral effects of low doses of apomorphine. Adv Biochem Psychopharmacol (1978) 1.12
Psychostimulant sensitization: differential changes in accumbal shell and core dopamine. Eur J Pharmacol (2000) 1.12
A role for dopamine D1 receptors of the nucleus accumbens shell in conditioned taste aversion learning. J Neurosci (2001) 1.11
Profound depression of mesolimbic dopamine release after morphine withdrawal in dependent rats. Eur J Pharmacol (1991) 1.10
Depression of mesolimbic dopamine transmission and sensitization to morphine during opiate abstinence. J Neurochem (1992) 1.08
Noradrenaline transporter blockers raise extracellular dopamine in medial prefrontal but not parietal and occipital cortex: differences with mianserin and clozapine. J Neurochem (2004) 1.08
Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential? Psychopharmacology (Berl) (1994) 1.06
Ethanol preferentially stimulates dopamine release in the nucleus accumbens of freely moving rats. Eur J Pharmacol (1985) 1.05
Behavioural sensitization after repeated exposure to Delta 9-tetrahydrocannabinol and cross-sensitization with morphine. Psychopharmacology (Berl) (2001) 1.05
Adenosine, adenosine A 2A antagonists, and Parkinson's disease. Parkinsonism Relat Disord (2009) 1.04
Differential changes in accumbens shell and core dopamine in behavioral sensitization to nicotine. Eur J Pharmacol (2000) 1.04
Evidence for dopamine receptors mediating sedation in the mouse brain. Nature (1976) 1.02
Altered cytokine and BDNF levels in autism spectrum disorder. Neurotox Res (2013) 1.01
Preferential stimulation of dopamine release in the nucleus accumbens by opiates, alcohol, and barbiturates: studies with transcerebral dialysis in freely moving rats. Ann N Y Acad Sci (1986) 1.00
Impaired long-term potentiation induction in dentate gyrus of calretinin-deficient mice. Proc Natl Acad Sci U S A (1997) 0.99
Cannabinoid CB(1) receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo. Eur J Pharmacol (2000) 0.97
Mu opioid receptor signaling in morphine sensitization. Neuroscience (2003) 0.96
SCH 23390 blocks drug-conditioned place-preference and place-aversion: anhedonia (lack of reward) or apathy (lack of motivation) after dopamine-receptor blockade? Psychopharmacology (Berl) (1989) 0.96
Changes in h-reflex amplitude during massage of triceps surae in healthy subjects. J Orthop Sports Phys Ther (1990) 0.96
Hemispheric control of unilateral and bilateral movements of proximal and distal parts of the arm as inferred from simple reaction time to lateralized light stimuli in man. Exp Brain Res (1980) 0.95
An apparatus for producing small-amplitude high-frequency sinusoidal stretching of the muscle. Arch Ital Biol (1970) 0.95
Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat. Brain Res (1979) 0.94
Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 2. Place-preference and brain microdialysis studies in rats. Behav Pharmacol (1998) 0.94
Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors. Neuroscience (2000) 0.94
Decrease in basal dopamine levels in the nucleus accumbens shell during daily drug-seeking behaviour in rats. Brain Res (2002) 0.93
Cannabinoid penetration into mouse brain as determined by ex vivo binding. Eur J Pharmacol (1999) 0.93
Dopamine-dependent behavioural stimulation by non-peptide delta opioids BW373U86 and SNC 80: 1. Locomotion, rearing and stereotypies in intact rats. Behav Pharmacol (1998) 0.93
Telomere length maintenance in aging and carcinogenesis. Int J Oncol (2000) 0.92
Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats. Drug Alcohol Depend (2000) 0.92
(D-Ala2)deltorphin II: D1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J Neurosci (1991) 0.92
Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine. Neuroscience (1999) 0.91
Acute stress induces time-dependent responses in dopamine mesolimbic system. Brain Res (1991) 0.91
Mianserin markedly and selectively increases extracellular dopamine in the prefrontal cortex as compared to the nucleus accumbens of the rat. Psychopharmacology (Berl) (1996) 0.91
Adenosine A2A receptor antagonism potentiates L-DOPA-induced turning behaviour and c-fos expression in 6-hydroxydopamine-lesioned rats. Eur J Pharmacol (1997) 0.91
Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment. Eur J Neurosci (2005) 0.91
Genetic Variability of Grapevine Pinot gris virus and Its Association with Grapevine Leaf Mottling and Deformation. Phytopathology (2015) 0.91
Serotonin release estimated by transcortical dialysis in freely-moving rats. Neuroscience (1989) 0.90
Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum. Brain Res (1987) 0.90
Non-psychostimulant drugs of abuse and anxiogenic drugs activate with differential selectivity dopamine transmission in the nucleus accumbens and in the medial prefrontal cortex of the rat. Psychopharmacology (Berl) (1996) 0.90
Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature (1977) 0.89
Benzodiazepine receptor binding in young, mature and senescent rat brain and kidney. Neurobiol Aging (1981) 0.89
Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592. J Neurochem (1992) 0.89
5-HT3 receptor antagonists block morphine- and nicotine-induced place-preference conditioning. Eur J Pharmacol (1988) 0.89
Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol. Eur J Pharmacol (1999) 0.89
Caffeine and accumbens shell dopamine. J Neurochem (2007) 0.88
Immunohistochemical telomeric-repeat binding factor-1 expression in gastrointestinal tumors. Oncol Rep (2000) 0.88
5HT3 receptor antagonists block morphine- and nicotine- but not amphetamine-induced reward. Psychopharmacology (Berl) (1989) 0.88
Chronic ethanol consumption in rats: correlation between memory performance and hippocampal acetylcholine release in vivo. Neuroscience (1996) 0.88
Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. Eur J Pharmacol (1999) 0.88
Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport (1998) 0.88
Synchronous pattern distinguishes resting tremor associated with essential tremor from rest tremor of Parkinson's disease. Parkinsonism Relat Disord (2010) 0.88
DJ-1 is a Parkinson's disease susceptibility gene in southern Italy. Clin Genet (2009) 0.87
Blockade of delta-opioid receptors in the nucleus accumbens prevents ethanol-induced stimulation of dopamine release. Eur J Pharmacol (1993) 0.87
Differential roles of splanchnic and peripheral tissues in determining diurnal fluctuation of glucose tolerance. Am J Physiol (1989) 0.87
Cannabinoid facilitation of behavioral and biochemical hedonic taste responses. Neuropharmacology (2011) 0.87
Role of vesicular dopamine in the in vivo stimulation of striatal dopamine transmission by amphetamine: evidence from microdialysis and Fos immunohistochemistry. Neuroscience (1995) 0.87
Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone. J Psychopharmacol (1996) 0.87
Blockade of A2a adenosine receptors positively modulates turning behaviour and c-Fos expression induced by D1 agonists in dopamine-denervated rats. Eur J Neurosci (1996) 0.86
Biochemical and behavioural properties of clozapine. Psychopharmacology (Berl) (1989) 0.86